Market Cap

ALK-Abello A-S Market Capitalization:

kr.20.14 Billion

DKK as of Jan. 1, 2023

US$2.89 Billion

business ALK-Abello A-S Company Profile

ALK-Abello A-S Main Stock Listing

show_chart OMXC: ALK.B

Market Capitalization History of ALK-Abello A-S

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $304.61 B
CSL Limited $93.24 B
Regeneron Pharmaceuticals, Inc. $79.53 B
Marinomed Biotech AG $76.72 B
Vertex Pharmaceuticals Incorporated $74.13 B
Sector: Healthcare
Company Market Cap (USD)
UnitedHealth Group $495.37 B
Johnson & Johnson $461.85 B
Lilly $347.61 B
Novo Nordisk $304.61 B
Pfizer $287.63 B

Yearly evolution of ALK-Abello A-S market cap

Date Market Cap YoY Change
Jan. 1, 2023 kr.20.14 B -32.30%
Jan. 1, 2022 kr.29.76 B 15.70%
Jan. 1, 2021 kr.25.72 B 33.78%
Jan. 1, 2020 kr.19.23 B 79.28%
Jan. 1, 2019 kr.10.72 B 31.76%
Jan. 1, 2018 kr.8.14 B -24.93%
Jan. 1, 2017 kr.10.84 B 6.95%
Jan. 1, 2016 kr.10.14 B 26.36%
Jan. 1, 2015 kr.8.02 B 3.87%
Jan. 1, 2014 kr.7.72 B 73.80%
Jan. 1, 2013 kr.4.44 B 23.63%
Jan. 1, 2012 kr.3.59 B -6.14%
Jan. 1, 2011 kr.3.83 B -13.09%
Jan. 1, 2010 kr.4.41 B -19.90%
Jan. 1, 2009 kr.5.50 B -5.85%
Jan. 1, 2008 kr.5.84 B -58.81%
Jan. 1, 2007 kr.14.18 B 82.17%
Jan. 1, 2006 kr.7.79 B -4.46%
Jan. 1, 2005 kr.8.15 B 134.77%
Jan. 1, 2004 kr.3.47 B 41.30%
Jan. 1, 2003 kr.2.46 B -2.13%
Jan. 1, 2002 kr.2.51 B -20.88%
Jan. 1, 2001 kr.3.17 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

ALK-Abello A-S Categories

Denmark languages Healthcare languages Biotechnology
Denmark Healthcare Denmark Biotechnology

Stocks & Indices

ALK-Abello A-S has the following listings and related stock indices.


Stock: OMXC: ALK.B

Stock: FSX: 4AJ

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.